Research Site 10001-042 — New Windsor, New York

Research Site 10001-042 is a clinical research site located in New Windsor, New York, United States 12553.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Research Site 10001-042 has participated in 2 clinical trials.

Therapeutic areas: ASCVD, Elevated Cholesterol, Heterozygous Familial Hypercholesterolemia.

Sponsors: The Medicines Company, Novartis Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in New Windsor

Browse all research sites in New York · View every site in New Windsor

• Research Site
• Mid Hudson Medical Research
• Mid Hudson Medical Research PLLC
• Novo Nordisk Investigational Site
• Mid Hudson Med Res-New Windsor
• Mid-Hudson Medical Research, PLLC - New Windsor
• GSK Investigational Site
• Clinical Research Site
• Pfizer Investigational Site
• Mid-Hudson Medical Research, PLLC - Hopewell Junction
• Synergy Research Site

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Site 10001-042?

Research Site 10001-042 has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Site 10001-042 conducted?

Research Site 10001-042 has 2 clinical trials on record. Their work covers ASCVD, Elevated Cholesterol, Heterozygous Familial Hypercholesterolemia.

Is Research Site 10001-042 accredited by Crixeo Clinical Trials?

Research Site 10001-042 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Site 10001-042?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.